Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 9:31 AM ET

Date/Time Source News Release
06/05/2025 07:32 AM EDT GlobeNewswire Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment
05/20/2025 09:00 AM EDT GlobeNewswire Clearmind Medicine to Host Live Webinar "Gazing Through the Crystal Ball" Featuring Leading Psychedelic Experts
05/12/2025 07:32 AM EDT GlobeNewswire Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
04/25/2025 07:59 AM EDT GlobeNewswire SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
04/25/2025 07:55 AM EDT GlobeNewswire Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
04/23/2025 08:25 AM EDT GlobeNewswire Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites
04/21/2025 09:15 AM EDT GlobeNewswire Clearmind Medicine to Host Live Webinar "Gazing Through the Crystal Ball" Featuring Leading Psychedelic Experts
04/17/2025 07:38 AM EDT GlobeNewswire Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
04/16/2025 08:40 AM EDT GlobeNewswire Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
04/10/2025 08:25 AM EDT GlobeNewswire Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder
Page

Additional News

As of June 11, 2025 • 9:31 AM ET

Date/Time Source News Release
06/05/2025 01:01 PM EDT PRISM News Clearmind Medicine Kicks Off Phase I/IIa Trial for CMND-100 in Alcohol Use Disorder
05/20/2025 10:46 AM EDT SeekingAlpha Psychedelic stocks rise as FDA chief's comments seen favorable to industry
04/21/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Contract Breaches and Patent Allowances Spell Different Fates For AI and Weight Loss Indices
03/15/2025 05:30 AM EDT US Earnings Reports Expected earnings - Clearmind Medicine Inc.
01/10/2025 01:27 PM EST SeekingAlpha Psychedelic drug developer Lykos could get lifeline from former Tesla board member
12/24/2024 08:30 AM EST 24/7 Market News IRB Approves Phase I/IIa clinical trial for Clearmind's CMND-100
12/24/2024 07:07 AM EST SeekingAlpha Clearmind Medicine receives IRB approval for Phase I/IIa clinical trial of CMND-100
11/06/2024 01:55 AM EST SeekingAlpha Massachusetts psychedelics legalization initiative poised to fail
11/04/2024 05:27 AM EST SeekingAlpha Legalizing psychedelics: Is Massachusetts next?
10/19/2024 09:40 AM EDT SeekingAlpha FDA is said to see "path forward" for ecstasy-based drug
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.